In a study of 124 patients with advanced breast, lung, and prostate cancers, a new, high-intensity genomic sequencing approach detected circulating tumour DNA at a high rate. In 89% of patients, at least one genetic change detected in the tumour was also detected in the blood. Overall, 627 (73%) genetic changes found in tumour samples were also found in blood samples with this approach.